Assembly Biosciences Reports Second Quarter 2024 Financial Results and Recent Updates
August 08, 2024 16:05 ET
|
Assembly Biosciences, Inc.
Dosing initiated in healthy participants in Phase 1a/b trial for ABI-5366 targeting recurrent genital herpes, with interim Phase 1a first-in-human data expected in Q3 2024 and interim Phase 1b data in...
AvePoint Announces Second Quarter 2024 Financial Results
August 08, 2024 16:05 ET
|
AvePoint, Inc.
Second quarter SaaS revenue of $53.6 million, representing 40% year-over-year growthSecond quarter Total revenue of $78.0 million, representing 20% year-over-year growthTotal ARR of $290.1 million,...
Cytokinetics Reports Second Quarter 2024 Financial Results
August 08, 2024 16:00 ET
|
Cytokinetics, Incorporated
Type B Meeting Held with FDA Related to Potential Risk Mitigation Strategies for Aficamten;Company Has Initiated Rolling NDA Submission FDA Cleared Protocol Amendment for FOREST-HCM Reducing...
Virios Therapeutics Announces Second Quarter 2024 Financial Results
August 08, 2024 09:15 ET
|
Virios Therapeutics
- Bateman Horne Center completed enrollment in its groundbreaking investigator-initiated Long-COVID phase 2a study featuring valacyclovir and celecoxib (IMC-2) - - Top-line results from the Bateman...
Quoin Pharmaceuticals Provides Corporate Update and Announces Second Quarter 2024 Financial Results
August 08, 2024 08:30 ET
|
Quoin Pharmaceuticals, Inc.
Quoin Broadens Product Portfolio through Research Agreement with University College Cork, Ireland Company Expands On-going Clinical Trials in Netherton Syndrome to Include International Sites ...
Barinthus Bio Reports Second Quarter 2024 Update on Corporate Developments and Financial Results
August 08, 2024 08:00 ET
|
Barinthus Biotherapeutics
Barinthus Bio Reports Second Quarter 2024 Update on Corporate Developments and Financial Results
Golden Matrix Group to Announce Second Quarter Financial Results on August 13th
August 08, 2024 08:00 ET
|
Golden Matrix Group Inc,
LAS VEGAS, NV, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Golden Matrix Group Inc. (NASDAQ: GMGI), a developer and licensor of online gaming platforms, systems, and gaming content, today announced that it...
Acorn’s Q2’24 EPS Improves to $0.11 vs. $0.04 on Revenue Increase in Remote Monitoring and Control Solutions for Backup Power Generators
August 08, 2024 07:58 ET
|
Acorn Energy, Inc.
ACFN: Acorn’s Q2’24 EPS Improves to $0.11 v. $0.04 on Continued Growth in Remote Monitoring and Control Solutions for Backup Power Generators. 11am Call.
Tourmaline Bio Reports Second Quarter 2024 Financial Results and Recent Business Highlights
August 08, 2024 07:30 ET
|
Tourmaline Bio, Inc.
Tourmaline Bio Reports Second Quarter 2024 Financial Results and Recent Business Highlights
Vital Farms Reports Second Quarter 2024 Financial Results and Raises Fiscal Year 2024 Guidance
August 08, 2024 07:20 ET
|
Vital Farms
Second Quarter Net Revenue of $147.4 million, up 38.5% versus Prior Year PeriodRaises Fiscal Year 2024 Outlook and Reiterates Long-term GuidancePlans for New State-of-the-Art Egg Washing and Packing...